LIfT BioSciences

Name: LIfT BioSciences - AI Visibility Score
Creator: Engagemii
Published: 2026-06-28T02:33:13.273Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

liftbiosciences.com

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. LIfT BioSciences just got measured.

5/10 means LIfT BioSciences is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About LIfT BioSciences

LIfT Biosciences is a pre-clinical stage biotech with The World’s only Neutrophil based Cell Therapy Platform. The LIfT platform is allogeneic and can be used to produce different Immuno-Modulating Alpha Neutrophils (IMANs) for treating a range of different therapeutic indications, including solid tumours.

Key Topics

Re-arming the innate immune system against solid tumours

Immunomodulatory Alpha Neutrophils (IMANs) are first-in-class, off-the-shelf neutrophil-lineage cell therapies designed to directly kill tumour cells and re-ignite anti-tumour immunity in cancer patients who progress. Our upcoming first-in-human Phase 1 clinical study will assess IMANs’ safety, biodistribution, and anti-tumour activity in patients with advanced cervical and head & neck cancers.